US$ 29.16
tirzepatide vs semaglutide efficacy weight loss comparison of liraglutide, semaglutide, and tirzepatie in semaglutide vs tirzepatide efficacy comparison
Description
Zepbound is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

This is a proven, safe way to do it
In another study, an 84-week open-label trial with about 800 participants, people taking CagriSema had an average of 23% weight loss versus about 25 to 26% for tirzepatide (Zepbound) at the highest dose

Saxenda may require long-term use

And of course, keep pens out of reach of kids and pets

Normal post-injection effects include mild redness, slight tenderness, and a small lump
